A newly released report shows 75% of lung cancers in an innovative early detection program at Sarasota Memorial are being diagnosed at the earliest, most treatable stages (I and II) -- greatly surpassing state and national averages.
Tuesday, April 14, 2026
SMH’s Kolschowsky Research and Education Institute is participating in two international research studies exploring potential gene therapy alternatives to bladder removal surgery. The Sarasota studies are being led by local principal investigator Robert I. Carey, MD, PhD, FACS, a urologist with Sarasota Memorial’s First Physicians Group and the Brian D. Jellison Cancer Institute.
Wednesday, December 17, 2025
An oncology counselor with Sarasota Memorial’s Brian D. Jellison Cancer Institute has been recognized for decades of extraordinary dedication and care for cancer patients
Tuesday, November 25, 2025
The Brian D. Jellison Cancer Institute team has been nationally recognized for catching early-stage lung cancer at double the rate achieved in most health systems across the nation.
Thursday, November 20, 2025
Sarasota Memorial thyroid/parathyroid specialist Ralph P. Tufano, MD, MBA, FACS, has been recognized among a panel of leading medical experts who have issued new guidelines for the treatment of differentiated thyroid cancer (DTC), the most prevalent cancer of the thyroid.
Friday, September 5, 2025